Company facts
- Headquarters
- Irvine, California
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 1,004+ filings
- On EDGAR
- CIK 1099800
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 30
News 8 of 59
Prospectuses and Registrations 8 of 9
- S-8 Registration statement for an employee plan Aug 4, 2026
- S-8 Registration statement for an employee plan Aug 6, 2025
- S-8 Registration statement for an employee plan Aug 6, 2025
- S-3ASR Automatic shelf registration Jul 21, 2025
- S-8 Registration statement for an employee plan Jul 31, 2024
- S-3ASR Automatic shelf registration Jul 22, 2022
- S-8 Registration statement for an employee plan May 7, 2021
- S-8 Registration statement for an employee plan May 7, 2021
Proxies 8 of 25
- DEFA14A Extra proxy material Mar 26, 2026
- DEFA14A Extra proxy material Mar 26, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 26, 2026
- DEFA14A Extra proxy material Apr 14, 2025
- DEFA14A Extra proxy material Mar 26, 2025
- DEFA14A Extra proxy material Mar 26, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 26, 2025
- DEFA14A Extra proxy material Mar 26, 2024
Ownership 8 of 850
- 4 Insider reported a trade Nov 9, 2026
- 4 Insider reported a trade Nov 9, 2026
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- 144 Notice of a proposed sale of restricted stock Nov 9, 2026
- 4 Insider reported a trade Oct 8, 2026
- 4 Insider reported a trade Sep 14, 2026
- 4 Insider reported a trade Sep 14, 2026
- 4 Insider reported a trade Sep 11, 2026
Other 8 of 31
- 11-K Employee stock plan report Jun 12, 2026
- 11-K Employee stock plan report Jun 12, 2026
- SD Conflict minerals disclosure May 27, 2026
- ARS Annual report sent to shareholders Mar 26, 2026
- 11-K Employee stock plan report Jun 17, 2025
- 11-K Employee stock plan report Jun 17, 2025
- SD Conflict minerals disclosure May 30, 2025
- ARS Annual report sent to shareholders Mar 26, 2025
What to read: Sep 2026 10-Q
SECSift found 3 of 11 sections worth reading, with 0 positive, 13 notable, and 6 negative flags.
Financial Statements (Item 1)
Financial statements with large impairment, tax dispute escalation, VIE consolidation, and buyback detail.Notable- Acquired Autus in Feb 2026 for $128.9M, with up to $132.5M in milestone payments; recorded $65.2M gain on remeasurement.
- Securities class action settled for immaterial amount; court preliminarily approved Aug 2026, final hearing Dec 2026.
- Effective tax rate jumped to 31.2% for 9M 2026 from 16.1% due to $174.4M valuation allowance from California law change.
- Gross liability for uncertain tax positions rose to $817.5M at Sep 2026 from $767.4M at Dec 2025.
Management's Discussion (Item 2)
Massive IRS disputes, impairment charges, and VIE consolidation dominate this MD&A.Notable- Acquired Autus for $129M in Feb 2026; up to $133M in contingent milestones possible.
- Consolidated a VIE in May 2026 after amending agreements; results included from that date.
- Pillar Two expected to add ~$45M in tax expense in 2026 before offsets.
- Repurchased $696.6M in shares during first nine months of 2026; $1.3B remaining authorized.
Negative- $220M impairment in 2026, mostly from full write-off of an in-process R&D asset.
- $174M valuation allowance booked due to California law limiting R&D credit carryforwards.
- IRS seeks $269M additional tax for 2015-2017; company made $380M deposits and plans to sue.
- IRS proposes $1.8B in taxable income adjustments for 2018-2020 plus 40% penalties; company disputes.
- IRS issued third NOPA with 40% transfer pricing penalties for 2018-2020; company disputes.
Other Information (Item 5)
New executive severance plan with multipliers and CEO's 10b5-1 sale of 145,696 shares.Notable- CEO's 10b5-1 plan to sell 145,696 shares starting Nov 9, 2026, through May 14, 2027.
- New Executive Severance Plan approved Nov 3, 2026, replacing prior change-in-control agreements.
- CEO's Severance Multiplier is 2.0; Change in Control Severance Multiplier is 3.0.
- CFO's Severance Multiplier is 1.0; Change in Control Severance Multiplier is 2.0.
- No tax gross-up provision; payments may be reduced to avoid excise tax under Section 280G.
What changed: Sep 2026 vs. Jun 2026
About 13% of EW's Sep 2026 10-Q is new information. 37 paragraphs were added, 110 changed, and 24 removed. Below are the most important lines SECSift identified.
Changed
- Cash paid for income taxes for nine months fell to $185.3M from $458.0M, down 59.5%.
- Net income from continuing operations for nine months fell to $923.5M from $991.8M, down 6.9%.
- Net sales for first nine months of 2026 were $5.1 billion, up $607.1 million from $4.5 billion in prior year.
- Impairment of intangible assets rose to $220.2M from $40.0M in Q3 2025 due to full write-off of an IPR&D asset.
- Provision for income taxes for nine months rose to $418.5M from $190.7M, more than doubling.
- Exhibit 32 changed from 'Furnished herewith' to '§ Furnished herewith' with a new § symbol.
- Gross profit as a percentage of sales was consistent with last year, not decreased as in prior filing.
Everything here comes from Edwards Lifesciences Corp's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Nov 4, 2026, from the 10-Q for Sep 2026.